Not provided
Not provided
Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2018-A01444-51 | Other Identifier | ID-RCB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The effectiveness of outpatient management of minor TIAs and strokes in the context of a dedicated outpatient pathway with specialized care has been demonstrated and has resulted in an 80% decrease in stroke in the year followed the AIT (EXPRESS and SOS-TIA studies) At the same time, few studies have been conducted on their economic interest and none in France.
Patient's typology (younger patient, no sequel, no disability) with Transient ischemic attack (TIA) and minor stroke (MS) makes them compatible with ambulatory management.
Only two hospitals in France can take care patients with TIA or MS in an outpatient setting :Bichat hospital in Paris and Toulouse University Hospital. The effectiveness of this management has been demonstrated since recurrence stroke risk is reduced by 80% at one year. An English study (EXPRESS study) [2] showed a gain of 624 pounds with an ambulatory management compared to a conventional one. No studies are available in France on this subject.
The aim of this study is to test the feasibility of a collection of medical and economic data on a prospective way. The investigators collect medical (Cerebrovascular events, Stroke) and economic (direct and indirect costs) data concerning patients who were managed in TIA clinic in Toulouse Hospital. The medical data will be compiled with available French and International literature. The economic data will be compiled with available data in PMSI and health insurance database. This study aims to prepare a multicenter cohort to compare the cost effectiveness ratio between ambulatory and conventional management.
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| The average cost-effectiveness ratio at 3 month | The average cost-effectiveness ratio at 3 month where the effectiveness is the 3-month cerebro vascular event rate and the costs taken into account are medical and non-medical direct costs and indirect costs limited to work stoppages. | 3 months |
| Measure | Description | Time Frame |
|---|---|---|
| Percentage of full cost collection | Percentage of patients for whom total direct medical, direct non-medical, and indirect costs could be collected by comparing with health insurance data | 1 year |
| Concordance between monitoring data collected in different database |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Stroke patients, to adapt to the recent change in the typology of new ischemic stroke in Western Europe, which for the most part are transient (30%) or minor ischemic strokes (35%). %).
The profile of these patients is indeed compatible with outpatient care which should lead to the adaptation of the offer of care.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Hélène Derumeaux-Burel, MD | Contact | 05 61 77 87 75 | derumeaux.h@chu-toulouse.fr | |
| Isabelle Olivier, PhD | Contact | 05 61 77 70 51 | 33 | olivier.i@chu-toulouse.fr |
| Name | Affiliation | Role |
|---|---|---|
| Hélène Derumeaux-Burel, MD | University Hospital, Toulouse | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University Hospital Toulouse | Toulouse | 31059 | France |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D002546 | Ischemic Attack, Transient |
| ID | Term |
|---|---|
| D002545 | Brain Ischemia |
| D002561 | Cerebrovascular Disorders |
| D001927 | Brain Diseases |
| D002493 | Central Nervous System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Concordance between prospectively collected monitoring data, supplemented by data from the PMSI database of Toulouse University Hospital and data extracted from the health insurance database via NIR. |
| 1 year |
| Recurrence rate of cerebro and cardiovascular events at 7 days | Recurrence rate of cerebro and cardiovascular events at 7 days : Stroke, myocardial infarction, vascular death within 30 days of stroke or MI | 7 days |
| Recurrence rate of cerebro and cardiovascular events at 3 months | Recurrence rate of cerebro and cardiovascular events at 3 months : Stroke, myocardial infarction, vascular death within 30 days of stroke or MI | 3 months |
| Recurrence rate of cerebro and cardiovascular events at one year | Recurrence rate of cerebro and cardiovascular events at one year : Stroke, myocardial infarction, vascular death within 30 days of stroke or MI | one year |
| Average cost-effectiveness ratio at one year | The average cost - effectiveness ratio with the criterion of effectiveness the recurrence rate for cardiovascular events at one year (stroke, myocardial infarction, vascular death occurring within 30 days after a stroke or an IDM), and as cost criteria, direct medical and non-medical costs and indirect costs limited to work stoppages | one year |
| Percentage of patients treated in TIA clinic who had first medical contact with a senior | Percentage of patients attending the AIT Clinic who had first medical contact with a senior neurology | 1 day |
| Percentage of patients with statin prescription at discharge | Percentage of patients with statin prescription at discharge | 1 day |
| D009422 | Nervous System Diseases |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |